TY - JOUR
T1 - The long-term effect of the combination of estramustine and cyclophosphamide to castration resistant prostate cancer
T2 - A case report
AU - Saegusa, Michihisa
AU - Nishimura, Shingo
AU - Edamura, Kouhei
AU - Kurose, Kyouhei
AU - Ebara, Shin
PY - 2012/2/20
Y1 - 2012/2/20
N2 - A 66-year-old man was diagnosed as prostate cancer of T2aN1M0, GS4+5. After CAB, radical prostatectomy was performed, and hormonal therapy was continued after operation. However he gadually became nonrespondent. At the time PSA become 17.38 ng/ml, combined application of estramustine (EMP) and cyclophosphamide (CPA) was started. PSA decreased gradually, and became below 0.01 ng/ml 14 months later, there-fore both medicines were discontinued on the 24th month. Adverse effects were only slight bone-marrow suppression. After 41 months, PSA became 0.02 ng/ml, and bone abnormality by CT also improved. The longterm effect of EMP and CPA, to castration resistant prostate cancer patient was thus achieved.
AB - A 66-year-old man was diagnosed as prostate cancer of T2aN1M0, GS4+5. After CAB, radical prostatectomy was performed, and hormonal therapy was continued after operation. However he gadually became nonrespondent. At the time PSA become 17.38 ng/ml, combined application of estramustine (EMP) and cyclophosphamide (CPA) was started. PSA decreased gradually, and became below 0.01 ng/ml 14 months later, there-fore both medicines were discontinued on the 24th month. Adverse effects were only slight bone-marrow suppression. After 41 months, PSA became 0.02 ng/ml, and bone abnormality by CT also improved. The longterm effect of EMP and CPA, to castration resistant prostate cancer patient was thus achieved.
UR - http://www.scopus.com/inward/record.url?scp=84857517087&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857517087&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84857517087
SN - 0385-2393
VL - 66
SP - 167
EP - 170
JO - Japanese Journal of Clinical Urology
JF - Japanese Journal of Clinical Urology
IS - 2
ER -
